Medical Facilities Corporation

TSX:DR.TO

Medical - Care Facilities

Healthcare
$17.43 +1.01%

+$0.18 today

Market cap
$282.59M
Beta
0.34
P/E (TTM)
8.7
EPS (TTM)
$1.47
Dividend yield
2.00%
52W Low $13.59High $18.79

Volume 0.04M

Average 0.02M

DR.TO Common Stock Repurchased

Cash spent buying back the company's own shares.

Medical Facilities CorporationTSX: DR.TO

Common Stock Repurchased · Q1 FY2026 · quarter ended Mar 2026

Common stock repurchased declines year over year

Q1 FY2026 common stock repurchased of $3.81M (cash outflow) fell 91.7% year over year, behind the -61.3% change in trailing-twelve-month common stock repurchased. Sequentially, it fell 26.7% from the prior quarter. Over 3 fiscal years it compounded at +19.1% a year.

Context

  • Common stock repurchased amounted to 25.0% of revenue in FY2025, up 20.0 pp from a year earlier.
  • Common stock repurchased grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -91.7% toward the trailing-twelve-month pace of -61.3%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$3.81M-26.7% QoQ
Last fiscal yearDec 2025
-$64.78M+289.9% YoY
LTMMar 2026
-$23.44M-61.3% YoY
Common Stock Repurchased past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-91.7%——
1 year+289.9%——
3-year CAGR+19.1%——
5-year CAGR——
10-year CAGR——

Common Stock Repurchased history

USD · from the cash flow

Latest · FY2025
(64.78M) USD
Year-over-year change
-289.9%

Common Stock Repurchased vs competitors

How DR.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so common stock repurchased is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -61.3% is the lowest of 4, against a peer median of +100.0%.
  • Common stock repurchased amounts to 7.7% of revenue for DR.TO, versus a peer median of 0.0%.
DR.TO Competitors
Common Stock Repurchased for DR.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DR.TOMedical Facilities CorporationLTM Mar 2026$23.44M USD-61.3%+19.1%7.7%
CRRX.TOCareRx CorporationLTM Mar 2026CA$2.44M CAD+107.0%—0.7%
TSND.TOTerrAscend Corp.LTM Mar 2026$255.04K USD-42.8%—0.1%
EPRX.TOEupraxia Pharmaceuticals Inc.LTM Mar 2026$0 USD———
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$0 USD+100.0%—0.0%
PRN.TOProfound Medical Corp.LTM Mar 2026$0 USD——0.0%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$0 CAD——0.0%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$0 CAD——0.0%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026CA$0 CAD——0.0%
Peer median (excluding DR.TO) —+100.0%—0.0%

Competitors are the stored peer set for DR.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income46.49M12.3M44M105.56M21.08M
Depreciation & Amortization26.77M20.76M21.54M19.37M15.66M
Deferred Income Tax4.4M5.21M8.33M(3.67M)6.01M
Stock-Based Compensation292K(667K)(397K)(246K)0
Change in Working Capital(10.45M)(6.21M)(488K)(1.64M)(3.96M)
Accounts Receivables(1.23M)(2.6M)1.03M5.23M(4.02M)
Inventory659K1.42M(205K)(476K)(659.34K)
Accounts Payables(525K)2.46M(2.48M)(495K)1.86M
Other Working Capital(9.35M)(7.5M)1.17M(5.9M)(1.14M)
Other Non-Cash Items8.14M25.63M(183K)(36.09M)7.16M
Operating Cash Flow75.64M57.01M72.71M83.28M45.95M
Capital Expenditures(8.42M)(6.72M)(16.05M)(7.07M)(4.96M)
Acquisitions (Net)(267K)943K2.39M92.49M826.21K
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(267K)943K2.39M00
Investing Cash Flow(8.69M)(5.78M)(13.67M)85.42M(4.14M)
Debt Repayment(30.05M)(6.47M)(28.84M)(32.82M)(2.62M)
Common Stock Issued00000
Common Stock Repurchased(2.07M)(38.38M)(7.42M)(16.61M)(64.78M)
Dividends Paid(6.92M)(7.5M)(6.07M)(6.1M)(5.18M)
Other Financing Activities(33.02M)(25M)(27.49M)(28.73M)(34.72M)
Financing Cash Flow(72.06M)(77.35M)(69.83M)(84.26M)(107.3M)
Effect of Forex Changes(34K)(3K)(34K)(59K)(4.77M)
Net Change in Cash(5.14M)(26.12M)(10.81M)84.38M(70.26M)
Free Cash Flow67.22M50.3M56.66M76.22M40.99M

Medical Facilities Corporation

TSX:DR.TO

Intrinsic Alpha fair value

Locked

Current Price

$17.43

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.